Disease Areas
Diabetes
Obesity
Cardiovascular Disease (CVD)
Chronic Kidney Disease (CKD)
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Neurodegenerative Diseases
Haemophilia
Sickle Cell Disease
Primary Hyperoxaluria
Growth Hormone Disorders
Hormone Replacement Therapy
Congresses
Scientific Publications
IME
Search Science Hub
Register
Login
My Account
Welcome to Novo Nordisk Science Hub
Are you a healthcare professional?
No
Yes
Congresses
ESC 2026
Breaking boundaries in cardiometabolic care with oral and injectable GLP-1RAs
ESC 2026
28 - 31 August 2026
Breaking boundaries in cardiometabolic care with oral and injectable GLP-1RAs
Share
Copy link
{{pageUrl}}
Keywords
Cardiovascular Disease
Congress industry session
GLP-1 RA
Semaglutide
